J&J PAYING $181M TO SETTLE CLAIMS OVER RISPERDAL MEDICATION ADS
By: Chris Placitella @ Sep 02, 2012
A Johnson & Johnson subsidiary agreed Thursday to pay $181 million to settle dozens of states’ claims that it engaged in illegal off-label marketing of antipsychotic drugs, with New Jersey to receive $5.3 million. Janssen Pharmaceuticals Inc. of Titusville improperly marketed Risperdal, Risperdal Consta, Risperdal M-Tab and Invega, in violation of federal law, according […]